Therapy Areas: Diabetes
6 October 2026 - Mozart Therapeutics Inc, a developer of CD8 Treg network modulators for the treatment of autoimmune disease, announced on Monday the presentation of clinical and preclinical data for ...
5 October 2026 - Aroa Biosurgery Limited (ASX:ARX), a New Zealand-based soft tissue regeneration company, on Monday reported positive results from a prospective, multicentre randomised controlled tria...
30 September 2026 - Medicine company Eli Lilly and Company (NYSE: LLY) revealed on Wednesday that it has achieved positive 48-week Phase 2b results for EloraTZP, its investigational combination of elo...
29 September 2026 - Lakewood-Amedex Biotherapeutics Inc (NASDAQ:LABT), a clinical-stage biotechnology company focused on advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials f...
25 September 2026 - Biotechnology company REGENXBIO Inc (Nasdaq:RGNX) on Thursday announced positive long-term follow-up data from the Phase II ALTITUDE study of investigational surabgene lomparvovec ...
24 September 2026 - Life sciences and diagnostics company Revvity Inc (NYSE:RVTY) on Thursday launched the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified multiplex autoantibody detection solu...